GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Deferred Tax

G.Barekat Pharm (XTEH:BRKT1) Deferred Tax : IRR0 Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

G.Barekat Pharm's change in deferred tax for the six months ended in Mar. 2017 was IRR0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.

G.Barekat Pharm Deferred Tax Historical Data

The historical data trend for G.Barekat Pharm's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Deferred Tax Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Deferred Tax
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Deferred Tax - -

G.Barekat Pharm Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G.Barekat Pharm Deferred Tax Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Deferred Tax
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines